Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D.
Clinical Nephrology 29(1): 52
1988
ISSN/ISBN: 0301-0430 PMID: 2838205 Document Number: 309589
Document emailed within 1 workday
Related Documents
Canafax, D.M.; Simmons, R.L.; Sutherland, D.E.; Fryd, D.S.; Strand, M.H.; Ascher, N.L.; Payne, W.D.; Najarian, J.S. 1986: Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine Transplantation Proceedings 18(2 Suppl 1): 192-196Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Kapoor, N.; Copelan, E.A.; Tutschka, P.J. 1989: Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent Transplantation Proceedings 21(1 Part 3): 3095-3096
Siennicka, J.; Durlik, M.; Litwińska, B.; Chmura, A.; Lewandowska, D.; Lao, M.; Paczek, L.; Kańtoch, M. 1999: Identification of cytomegalovirus (CMV) infection by different laboratory methods in renal transplant recipients undergoing triple-drug immunosupressive treatment Acta Microbiologica Polonica 48(1): 61-71
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Mourad, G.; Chong, G.; Pouliquen, M.; Ruiz, G.; Mandin, J.; Mion, C. 1984: Withdrawal of azathioprine and antilymphocyte globulins in kidney transplant recipients with cytomegalovirus Transplantation Proceedings 16(5): 1313-1315
Cornella, C.; Torazza, M.C.; Strippoli, G.F.M.; Segoloni, G. 2007: Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24 Suppl. 37: S165-S178
Gruber, S.A.; Pescovitz, M.; Simmons, R.L.; Najarian, J.S.; Ascher, N.L.; Payne, W.D.; Sutherland, D.E.; Elick, B.; Fryd, D.S. 1987: Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin Transplantation Proceedings 19(1 Pt 2): 1815-1816
Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18
Gondo, H. 1998: Cytomegalovirus infection in transplant recipients Nihon Rinsho. Japanese Journal of Clinical Medicine 56(1): 173-178
Jankowski, M.; Gut, W.; Nawrocka, E.; Gradowska, L.; Roncewicz, Z.; Rowińska, D. 1982: Cytomegalovirus antibodies in renal transplant recipients Acta Microbiologica Polonica 31(3-4): 279-285
Sumrani, N.; Delaney, V.; Ding, Z.; Davis, R.; Butt, K.; Hong, J. 1991: Is cyclosporine indicated in HLA-identical renal transplant recipients? Transplantation Proceedings 23(1 Part 2): 1239-1240
Winkler, M.; Haller, G.; Oldhafer, K.; Bechstein, W.O.; Kattner, A.; Maibücher, A.; Färber, L.; Ringe, B.; Christians, U.; Neuhaus, P.; Pichlmayr, R. 1996: A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients Transplantation 62(8): 1063-1068
Ducloux, D.; Fournier, V.; Rebibou, J.M.; Bresson-Vautrin, C.; Gibey, R.; Chalopin, J.M. 1998: Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine Clinical Nephrology 49(4): 232-235
Noel, C.; Dhondt, J.L.; Walter, M.P.; Dracon, M.; Pruvot, F.R.; Wattine, O.; Lelievre, G.; Dequiedt, P. 1987: Neopterin excretion for kidney transplant monitoring: relationship with antilymphocyte globulin treatment Transplantation Proceedings 19(1 Part 2): 1689-1690
Carmellini, M.; Romagnoli, J.; Pietrabissa, A.; Di Stefano, R.; Oleggini, M.; Rindi, P.; Rizzo, G.; Mosca, F. 1994: Evaluation of infections in renal transplant recipients treated with cyclosporine Transplantation Proceedings 26(5): 2658-2659
Mihatsch, M.J.; Thiel, G.; Basler, V.; Ryffel, B.; Landmann, J.; von Overbeck, J.; Zollinger, H.U. 1985: Morphological patterns in cyclosporine-treated renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 101-116
Laine, J.; Holmberg, C. 1996: Tubular effects of cyclosporine in pediatric renal transplant recipients Transplantation Proceedings 28(4): 2104-2106
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263